Nucleix
Agent30Agent Readiness: 30/100. Below median. Measured by StartupHub.ai. Median 41.Trust84Data Trust: 84/100. Top 25%. Measured by StartupHub.ai. Median 61.Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.
About
Nucleix is a liquid biopsy company focused on revolutionizing cancer treatment through earlier disease detection. They leverage NGS-based and PCR-based technology to identify methylation changes, offering a pioneering testing approach that aims to detect cancer at a stage where intervention can have the greatest impact for patients.
Similar companies
Comprehensive whole-genome monitoring for cancer recurrence and progression.
Shares Healthcare, Genomics
Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.
Shares Healthcare, Diagnostics
BioControl develops advanced diagnostic solutions for infectious diseases and cancer.
Shares Healthcare, HealthTech
Develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need.
Shares Healthcare, Diagnostics
Develops a computational model of the human body for drug discovery and development.
Shares Healthcare, Biomarkers
Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.
Shares Healthcare, Genomics
Key facts
- Website
- nucleix.com
- Headquarters
- Rehovot, Israel
- Founded
- 2008
- Employees
- 74
- Total funding
- $88M (Funding Round)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 5 Jan 2022 | Funding Round | $22M | |
| 7 Apr 2021 | Funding Round | $55M | |
| 30 Jul 2018 | Grant | $3M | |
| 23 May 2016 | Funding Round | $3M | |
| 16 Jun 2014 | Series A | $5M |
Tech stack
Detected on nucleix.com, last scanned 31 Oct 2026. Run your own scan
- Frontend
- jQuery
- Auth
- Okta
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Microsoft 365, SendGrid
Nucleix scores 40. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
5 reviews from Reddit gathered in one place
Armed With $55M in New Funding, Nucleix to Further Invest in Early-Stage Lung Cancer Dx.
D'après des experts européens de premier plan dans le domaine du cancer de la vessie, le test d'urine Bladder EpiCheck de Nucleix peut réduire les procédures invasives.
Führende europäische Blasenkrebsexperten: der Urintest Bladder EpiCheck von Nucleix kann invasive Verfahren reduzieren.
I principali esperti europei del cancro alla vescica dichiarano: il test delle urine Bladder EpiCheck di Nucleix può ridurre le procedure invasive.
El Nucleix Bladder EpiCheck Urine Test puede reducir los procedimientos invasivos.
Each quote is copied word for word and links to where it was posted. Promotion and off-topic posts are filtered out.
Frequently asked
Is Nucleix trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Nucleix is 84 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Nucleix raised?
Nucleix has raised a total of $88M in funding. The most recent round on record is Funding Round.
How many employees does Nucleix have?
Nucleix has approximately 74 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Nucleix
